Which of the following is an FDA label indication for Amiodarone Hydrochloride?

Which of the following is an FDA label indication for Amiodarone Hydrochloride?

• A. Hypertension management
• B. Atrial fibrillation
• C. Fluid retention
• D. Insomnia

Answer: (B)

Amiodarone Hydrochloride is primarily indicated for the treatment of certain types of lethal cardiac arrhythmias and plays a pivotal role in managing atrial fibrillation, particularly in situations where other therapies might be inadequate or inappropriate. As an antiarrhythmic agent, it helps restore normal sinus rhythm and control the heart rate in patients with atrial fibrillation, making it a critical medication in the cardiology field. This medication is not indicated for hypertension management, as its primary function is to regulate heart rhythms rather than lower blood pressure. Fluid retention and insomnia are also not recognized indications for amiodarone; its focus is entirely on cardiac rhythm stabilization. Therefore, its role in addressing atrial fibrillation aligns directly with its FDA-approved uses, cementing the relevance of this choice.

Amiodarone Hydrochloride is primarily indicated for the treatment of certain types of lethal cardiac arrhythmias and plays a pivotal role in managing atrial fibrillation, particularly in situations where other therapies might be inadequate or inappropriate. As an antiarrhythmic agent, it helps restore normal sinus rhythm and control the heart rate in patients with atrial fibrillation, making it a critical medication in the cardiology field.

This medication is not indicated for hypertension management, as its primary function is to regulate heart rhythms rather than lower blood pressure. Fluid retention and insomnia are also not recognized indications for amiodarone; its focus is entirely on cardiac rhythm stabilization. Therefore, its role in addressing atrial fibrillation aligns directly with its FDA-approved uses, cementing the relevance of this choice.